The Department of Justice (DOJ) announced that it has recovered over $3 billion in settlements and judgments under the False Claims Act in 2011. Of that $3 billion, $2.8 billion was recovered under the qui tam provisions of the False Claims Act. This is the second year in a row that the DOJ has recovered more than $3 billion under the Act and it has now collected more than $8.7 billion under the Act since January 2009. Nearly $2.2 billion of the $3 billion recovery was recovered from the pharmaceutical industry, including a $750 million settlement from GlaxoSmithKline and a $900 million settlement from eight drug manufacturers. The U.S. also recovered $422 million in procurement fraud cases, bringing the three year total of procurement fraud recovery to $1.5 billion.
For more information see: http://www.justice.gov/opa/pr/2011/December/11-civ-1665.html